Member Info for petrencf

It is claiming back now. Even of it would fall back to 70s, it would nothing to do with the fundamentals of the company rather then the general market sentiment. Update is due soon we shall see.

Well you are already in porfit with those buys. I think some investors were robbed this morning. Nothing sinks this ship but an FDA rejection, but I hope it will not happen.

Yes, we know, he has been selling. How did you calculate the 7 trading days?

It looks like somebody happy to buy more shares at this level.

SP 22p , target price 66p. And still sinking...

Decent set of results, recovery is in progress.

If my understanding is correct the company main business is the Hotter Shoes now with app. 50m revenue and 5m EBIDTA and 18m net debt. It looks cheap now.

Could somebody enlighten me why is this keep falling?

No, it is not. Based on 56p EPS forecast for FY22 it is around 20x at the SP of 1120p. (based on marketscreener)

Some massive buys this morning, not PI's, I guess.

Yes, it depends on the point of view.

Half year EPS was 3p, for the year It should be around 6-7p at least. The SP should be between 1.2-1.4 GBP with a PE of 20 considering the peers. And we talk about a a growth company, next year revenue and earnings should grow without the severe impact of national lockdowns on economy. This SP is a bad joke.

Considering this low SP I think the company could consider to buy back some shares. They have the money for it.

It is good to see that digital is growing but how much did it cost so far? Looking at the accounts it is approx. 26m since the acqusition of U Money. Massive numbers.

Why is the SP falling? It was a decent update. Returning to Pre-Covid profit level our EPS should be around 8p. And the business has been growing too. Interesting.

2m shares have been traded so far. Obvously many people is happy to buy at these levels.

This is a very important medical advance, the world should embrace this technology.
Good luck.

What kind of strategy is buying shares in tranches of 900?

Sincs FDA submission we got 2 RNS about promosing studies, 1 about the a nicely executed book build, a new contract was secured, and AN used his options (who would not have). I think the company does not have more information about the FDA approval than we have, otherwise they would be obliged to share it.

general market is down, i think some pi's panic selling caused the fall.